ZA201505050B - Oral transmucosal delivery of glatiramer acetate - Google Patents

Oral transmucosal delivery of glatiramer acetate

Info

Publication number
ZA201505050B
ZA201505050B ZA2015/05050A ZA201505050A ZA201505050B ZA 201505050 B ZA201505050 B ZA 201505050B ZA 2015/05050 A ZA2015/05050 A ZA 2015/05050A ZA 201505050 A ZA201505050 A ZA 201505050A ZA 201505050 B ZA201505050 B ZA 201505050B
Authority
ZA
South Africa
Prior art keywords
glatiramer acetate
transmucosal delivery
oral transmucosal
oral
delivery
Prior art date
Application number
ZA2015/05050A
Other languages
English (en)
Inventor
Pries Tanja
Huber Gerald
Stefan Ralph
Buerger Martina
Schweizer Stephan
Geister Ursula
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of ZA201505050B publication Critical patent/ZA201505050B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2015/05050A 2012-12-21 2015-07-14 Oral transmucosal delivery of glatiramer acetate ZA201505050B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261745243P 2012-12-21 2012-12-21
PCT/US2013/077041 WO2014100643A1 (en) 2012-12-21 2013-12-20 Oral transmucosal delivery of glatiramer acetate

Publications (1)

Publication Number Publication Date
ZA201505050B true ZA201505050B (en) 2016-10-26

Family

ID=50979258

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2015/05050A ZA201505050B (en) 2012-12-21 2015-07-14 Oral transmucosal delivery of glatiramer acetate

Country Status (15)

Country Link
US (1) US20150328277A1 (cg-RX-API-DMAC7.html)
EP (1) EP2934493A4 (cg-RX-API-DMAC7.html)
JP (1) JP2016503066A (cg-RX-API-DMAC7.html)
KR (1) KR20150111919A (cg-RX-API-DMAC7.html)
CN (1) CN104869984A (cg-RX-API-DMAC7.html)
AU (1) AU2013361057A1 (cg-RX-API-DMAC7.html)
BR (1) BR112015014092A2 (cg-RX-API-DMAC7.html)
CA (1) CA2895457A1 (cg-RX-API-DMAC7.html)
EA (1) EA201591187A1 (cg-RX-API-DMAC7.html)
HK (2) HK1214522A1 (cg-RX-API-DMAC7.html)
IL (1) IL239279A0 (cg-RX-API-DMAC7.html)
MX (1) MX2015007794A (cg-RX-API-DMAC7.html)
SG (1) SG11201504461QA (cg-RX-API-DMAC7.html)
WO (1) WO2014100643A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201505050B (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA025780B1 (ru) 2010-10-11 2017-01-30 Тева Фармасьютикал Индастриз Лтд. Цитокиновые биомаркеры в качестве биомаркеров, прогнозирующих клинический ответ на глатирамер ацетат
MX2014004309A (es) 2011-10-10 2015-07-06 Teva Pharma Polimorfismos de nucleotidos individuales utiles para predecir una respuesta clinica para el acetato de glatiramer.
UY35790A (es) 2013-10-21 2015-05-29 Teva Pharma Marcadores genéticos que predicen la respuesta al acetato de glatiramer
US10493122B2 (en) 2014-03-17 2019-12-03 Mapi Pharma Ltd. Sublingual delivery of glatiramer acetate
US10323289B2 (en) 2017-06-26 2019-06-18 Institut Pasteur Treatments to eliminate HIV reservoirs and reduce viral load

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0679002A (ja) * 1993-12-14 1994-03-22 Hisamitsu Pharmaceut Co Inc 経皮投与用パッチシステム
US6197331B1 (en) * 1997-07-24 2001-03-06 Perio Products Ltd. Pharmaceutical oral patch for controlled release of pharmaceutical agents in the oral cavity
US7022663B2 (en) * 2000-02-18 2006-04-04 Yeda Research And Development Co., Ltd. Oral, nasal and pulmonary dosage formulations of copolymer 1
US20020077278A1 (en) * 2000-06-05 2002-06-20 Yong V. Wee Use of glatiramer acetate (copolymer 1) in the treatment of central nervous system disorders
US20030175328A1 (en) * 2002-03-06 2003-09-18 Adi Shefer Patch for the controlled delivery of cosmetic, dermatological, and pharmaceutical active ingredients into the skin
NZ540318A (en) * 2002-10-31 2007-09-28 Umd Inc Therapeutic compositions for drug delivery to and through covering epithelia
EP2106790B1 (en) * 2004-03-12 2012-10-24 Biodel, Inc. Rapid acting drug delivery compositions
FI20041425A0 (fi) * 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
US20060205822A1 (en) * 2004-12-22 2006-09-14 Forest Laboratories, Inc. 1-Aminocyclohexane derivatives for the treatment of multiple sclerosis, emotional lability and pseudobulbar affect
US20060210616A1 (en) * 2005-03-17 2006-09-21 Linder Barry J Therapeutic patch for ophthalmologic and cosmetic use
US20070021325A1 (en) * 2005-07-21 2007-01-25 Mediplex Corporation Drug formulation containing a solubilizer for enhancing solubility, absorption, and permeability
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
KR100809404B1 (ko) * 2005-12-28 2008-03-05 (주)스피어테크 리포좀화 시킨 나노용매를 함유하는 경피흡수 점착시트형 화장료 조성물 및 제조방법
WO2007087188A2 (en) * 2006-01-20 2007-08-02 Merck & Co., Inc. Taste-masked tablets and granules
RU2436565C2 (ru) * 2006-02-17 2011-12-20 Новартис Аг Распадающиеся пероральные пленки
WO2008006226A1 (en) * 2006-07-14 2008-01-17 Wine, Harvey Transdermal formulations of synthetic cannabinoids and nano colloidal silica
AU2007329375A1 (en) * 2006-12-04 2008-06-12 The Board Of Trustees Of The University Of Illinois Compositions and methods to treat cancer with cupredoxins and CpG rich DNA
JP5177447B2 (ja) * 2007-06-07 2013-04-03 佐藤製薬株式会社 速溶性及び可撓性を有するフィルム製剤
WO2009005814A2 (en) * 2007-07-03 2009-01-08 Marchitto Kevin S Drug-delivery patch comprising a dissolvable layer and uses thereof
US20100278899A1 (en) * 2007-12-06 2010-11-04 Lintec Corporation Edible film

Also Published As

Publication number Publication date
WO2014100643A1 (en) 2014-06-26
JP2016503066A (ja) 2016-02-01
CN104869984A (zh) 2015-08-26
SG11201504461QA (en) 2015-07-30
HK1214522A1 (zh) 2016-07-29
WO2014100643A8 (en) 2015-06-25
EP2934493A4 (en) 2016-09-07
HK1214133A1 (zh) 2016-07-22
EP2934493A1 (en) 2015-10-28
EA201591187A1 (ru) 2016-03-31
CA2895457A1 (en) 2014-06-26
US20150328277A1 (en) 2015-11-19
AU2013361057A1 (en) 2015-07-30
BR112015014092A2 (pt) 2017-07-11
KR20150111919A (ko) 2015-10-06
MX2015007794A (es) 2015-09-04
IL239279A0 (en) 2015-07-30

Similar Documents

Publication Publication Date Title
IL236268B (en) Preparations for mucosal administration and their uses
PL2665431T3 (pl) Technika dostarczania leków
EP2575950A4 (en) ADMINISTRATION OF ORAL CARE PRODUCTS
AU2013344654A1 (en) Oral transmucosal drug delivery system
ZA201504191B (en) Transmucosal delivery of tocotrienol
ZA201505049B (en) Transmucosal delivery of glatiramer acetate
SG11201403875VA (en) Oral pharmaceutical composition
GB2497933B (en) Drug delivery technology
IL240666A0 (en) Pharmaceutical preparations for oral administration and their uses
SG11201404454VA (en) Improvements relating to medicament delivery devices
IL239279A0 (en) Oral transmucosal transmission of glatiramer acetate
ZA201502695B (en) Stable pharmaceutical composition of peginterferon alpha-2b
PT2922530T (pt) Formulações de acetato de caspofungina
PL2908837T3 (pl) Kompozycje do dostarczania leku
GB201110632D0 (en) Drug delivery formulations
PL2770944T3 (pl) Przezśluzówkowy implant dentystyczny
GB201121693D0 (en) Medicament delivery technology
GB201018760D0 (en) An oral dosage form
PH32012000577S1 (en) Design feature for an oral dosage form
PH32012000578S1 (en) Design feature for an oral dosage form
PH32012000575S1 (en) Design feature for an oral dosage form
PH32012000576S1 (en) Design feature for an oral dosage form
GB201005639D0 (en) Drug delivery formulations
GB201014931D0 (en) Enhanced delivery of nucleic